(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  18  19  20  21  22  23  24  25  26  27  Next »
Emerging Opportunities in the French Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the German Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the Italian Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the Japanese Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the Spanish Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the UK Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Emerging Opportunities in the US Hepatitis Diagnostic Testing Market

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
France Hepatitis A, B, C, D, E Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Germany Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
UK Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

 

$3900.00
       
Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers by Country

This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products by country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.


 

$3900.00
       
Ortho-Clinical Diagnostics: Sales, Market Shares and Competitive Position by Product and Country

This unique market intelligence report from Venture Planning Group provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Ortho-Clinical Diagnostics and its main competitors, as well as a profile of the company�s diagnostics business.



 

$3850.00
       
Tosoh: Diagnostics Sales, Market Shares and Competitive Position by Product and Country

This unique market intelligence report from Venture Planning Group provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Tosoh and its main competitors, as well as a profile of the company�s diagnostics business.



 

$3850.00
       
Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers

This report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.



 

$3850.00
       
« Previous     18  19  20  21  22  23  24  25  26  27   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X